摘要:
The present invention provides a L-succinylacylase consisting of: (a) a protein coded by a gene consisting of a nucleic acid sequence shown in SEQ ID No: 1; (b) a protein consisting of an amino acid sequence shown in SEQ ID No: 2; (c) a protein coded by a polynucleotide which hybridizes under a stringent condition with a nucleic acid sequence which is complementary to the nucleic acid sequence shown in SEQ ID No: 1 and having an L-succinylaminoacylase activity; or (d) a protein which consists of an amino acid sequence where one or several amino acid(s) is/are substituted, deleted, inserted and/or added in the protein consisting of the amino acid sequence shown in SEQ ID No: 2 and has an L-succinylaminoacylase activity. This enzyme is able to produce a sterically bulky unnatural amino acid such as L-tert-leucine etc. which is useful as an intermediate for pharmaceuticals.
摘要翻译:本发明提供了一种L-琥珀酰基酰化酶,其由以下组成:(a)由由SEQ ID No:1所示的核酸序列组成的基因编码的蛋白质; (b)由SEQ ID No:2所示的氨基酸序列组成的蛋白质; (c)由严格条件下与SEQ ID No:1所示核酸序列互补且具有L-琥珀酰氨基酰化酶活性的核酸序列杂交的多核苷酸编码的蛋白质; 或(d)由氨基酸序列组成的蛋白质,其中一个或多个氨基酸被取代,缺失,插入和/或添加在由SEQ ID No:2所示的氨基酸序列组成的蛋白质中 并具有L-琥珀酰氨基酰化酶活性。 该酶能够产生空间庞大的非天然氨基酸如L-叔亮氨酸等,其可用作药物的中间体。
摘要:
[Object] To provide: a novel diaphorase; a method for producing the diaphorase; and use of the diaphorase.[Solution] A diaphorase comprising any one of the following polypeptides (a) to (c): (a) a polypeptide having the amino acid sequence of SEQ ID NO: 1, (b) a polypeptide having the amino acid sequence of SEQ ID NO: 1 in which one or several amino acid residues are substituted, deleted, inserted, added, and/or inverted, and having diaphorase activity, and (c) a polypeptide having an amino acid sequence with 80% or more identity to the amino acid sequence of SEQ ID NO: 1, and having diaphorase activity.
摘要翻译:[目的]提供:一种新颖的心电图仪; 一种生产心肌黄酶的方法; 并使用心肌黄酶。 [解决方案]包含以下多肽(a)至(c)中的任一种的心肌黄酶:(a)具有SEQ ID NO:1的氨基酸序列的多肽,(b)具有SEQ ID NO: 其中一个或几个氨基酸残基被取代,缺失,插入,添加和/或倒转并具有心肌黄酶活性的NO:1,和(c)具有与氨基酸具有80%或更高同一性的氨基酸序列的多肽 酸序列,并具有心肌黄酶活性。
摘要:
The present invention provides an L-aminoacylase which is able to produce L-tert-leucine being useful as an intermediate for pharmaceuticals.A protein which is characterized in being represented by any of the following (a) to (d): (a) a protein coded by a gene consisting of a nucleic acid sequence shown in SEQ ID No: 1; (b) a protein consisting of an amino acid sequence shown in SEQ ID No: 2; (c) a protein coded by a polynucleotide which hybridizes under a stringent condition with a nucleic acid sequence which is complementary to the nucleic acid sequence shown in SEQ ID No: 1 and having an L-succinylaminoacylase activity; and (d) a protein which consists of an amino acid sequence where one or several amino acid (s) is/are substituted, deleted, inserted and/or added in the protein consisting of the amino acid sequence shown in SEQ ID No: 2 and has an L-succinylaminoacylase activity.
摘要翻译:本发明提供能够产生L-叔亮氨酸的L-氨基酸酰基酶,其可用作药物的中间体。 特征在于以下(a)〜(d)中任一项所示的蛋白质:(a)由由SEQ ID No:1所示的核酸序列组成的基因编码的蛋白质; (b)由SEQ ID No:2所示的氨基酸序列组成的蛋白质; (c)由严格条件下与SEQ ID No:1所示核酸序列互补且具有L-琥珀酰氨基酰化酶活性的核酸序列杂交的多核苷酸编码的蛋白质; 和(d)由氨基酸序列组成的蛋白质,其中一个或几个氨基酸被取代,缺失,插入和/或添加在由SEQ ID No:2所示的氨基酸序列组成的蛋白质中 并具有L-琥珀酰氨基酰化酶活性。
摘要:
The present invention provides a L-succinylacylase consisting of: (a) a protein coded by a gene consisting of a nucleic acid sequence shown in SEQ ID No: 1; (b) a protein consisting of an amino acid sequence shown in SEQ ID No: 2; (c) a protein coded by a polynucleotide which hybridizes under a stringent condition with a nucleic acid sequence which is complementary to the nucleic acid sequence shown in SEQ ID No: 1 and having an L-succinylaminoacylase activity; or (d) a protein which consists of an amino acid sequence where one or several amino acid(s) is/are substituted, deleted, inserted and/or added in the protein consisting of the amino acid sequence shown in SEQ ID No: 2 and has an L-succinylaminoacylase activity. This enzyme is able to produce a sterically bulky unnatural amino acid such as L-tert-leucine etc. which is useful as an intermediate for pharmaceuticals.
摘要翻译:本发明提供了一种L-琥珀酰基酰化酶,其由以下组成:(a)由由SEQ ID No:1所示的核酸序列组成的基因编码的蛋白质; (b)由SEQ ID No:2所示的氨基酸序列组成的蛋白质; (c)由严格条件下与SEQ ID No:1所示核酸序列互补且具有L-琥珀酰氨基酰化酶活性的核酸序列杂交的多核苷酸编码的蛋白质; 或(d)由氨基酸序列组成的蛋白质,其中一个或多个氨基酸被取代,缺失,插入和/或添加在由SEQ ID No:2所示的氨基酸序列组成的蛋白质中 并具有L-琥珀酰氨基酰化酶活性。 该酶能够产生空间庞大的非天然氨基酸如L-叔亮氨酸等,其可用作药物的中间体。
摘要:
The present invention provides an L-aminoacylase which is able to produce L-tert-leucine being useful as an intermediate for pharmaceuticals.A protein which is characterized in being represented by any of the following (a) to (d): (a) a protein coded by a gene consisting of a nucleic acid sequence shown in SEQ ID No: 1; (b) a protein consisting of an amino acid sequence shown in SEQ ID No: 2; (c) a protein coded by a polynucleotide which hybridizes under a stringent condition with a nucleic acid sequence which is complementary to the nucleic acid sequence shown in SEQ ID No: 1 and having an L-succinylaminoacylase activity; and (d) a protein which consists of an amino acid sequence where one or several amino acid (s) is/are substituted, deleted, inserted and/or added in the protein consisting of the amino acid sequence shown in SEQ ID No: 2 and has an L-succinylaminoacylase activity.
摘要翻译:本发明提供能够产生L-叔亮氨酸的L-氨基酸酰基酶,其可用作药物的中间体。 特征在于以下(a)〜(d)中任一项所示的蛋白质:(a)由由SEQ ID No:1所示的核酸序列组成的基因编码的蛋白质; (b)由SEQ ID No:2所示的氨基酸序列组成的蛋白质; (c)由严格条件下与SEQ ID No:1所示核酸序列互补且具有L-琥珀酰氨基酰化酶活性的核酸序列杂交的多核苷酸编码的蛋白质; 和(d)由氨基酸序列组成的蛋白质,其中一个或几个氨基酸被取代,缺失,插入和/或添加在由SEQ ID No:2所示的氨基酸序列组成的蛋白质中 并具有L-琥珀酰氨基酰化酶活性。